Y-Intercept »

Indivior Pharmaceuticals shares owned by Y-Intercept

Quarter-by-quarter ownership of Indivior Pharmaceuticals (INDV) shares owned by Y-Intercept from 13F filings

Historical chart of Y-Intercept investment in Indivior Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Indivior Pharmaceuticals held by Y-Intercept consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indivior Pharmaceuticals by Y-Intercept

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.6M 137k 41.03

More positions owned by Y-Intercept

Amazon (AMZN)
Apple (AAPL)
Boston Scientific Corporation (BSX)
Microsoft Corporation (MSFT)
Space Exploration Techn Corp Class A Com Stk (SPCX)
salesforce (CRM)
Cme (CME)
Cognizant Technology Solutio Cl A (CTSH)
Intuit (INTU)
Qualcomm (QCOM)
CBOE Holdings (CBOE)
NVIDIA Corporation (NVDA)
Accenture Plc Ireland Shs Class A (ACN)
Monolithic Power Systems (MPWR)
JPMorgan Chase & Co. (JPM)

View all positions for Y-Intercept

Top funds holding Indivior Pharmaceuticals

BlackRock
Vanguard Portfolio Management
Oaktree Capital Management
Vanguard Capital Management
State Street Corporation
Hanna Zanoni
Morgan Stanley
Two Seas Capital
Franklin Resources
Geode Capital Management
Madison Avenue Partners
Citadel Advisors
Mangrove Partners
Driehaus Capital Management
Millennium Management

View all funds holding Indivior Pharmaceuticals